Therapeutic Areas

Advancing Oncology Research

We have a long and proven track record in the development of small molecules for oncology.  We help our partners advance cancer programs from discovery through target identification/validation, hit identification/characterizationlead generation/optimization, IND filing and then NDA filing.

Axcelead focuses on biology and following the data.

We harness our wealth of expertise in target identification/validations, in vitro cell based assays, in vivo studies and translational research to achieve compounds with optimal profiles to perform well in the preclinical, clinical and real-world settings.

And given our success in this area, we are leveraging these learnings and expanding into immuno-oncology to create drugs that affect the cancer tumor microenvironment and host immunity.

Oncology Brochure

We are ready to partner with you.